Impact of Semaglutide on CD34+ EPC and Fat Derived MSC

Clinical trial NCT04126603 · COMPLETED

Trial details

NCT number: NCT04126603
Sponsor: Sabyasachi Sen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2019-08-01
Primary completion: 2023-10-25
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.